InMed Pharmaceuticals ( (INM) ) has shared an announcement.
InMed Pharmaceuticals is set to participate in the Fierce Biotech webinar on Alzheimer’s neuroinflammation, showcasing their drug candidate, INM-901. This innovative compound aims to mitigate neuroinflammation and promote brain cell communication, positioning InMed as a leader in Alzheimer’s research. The event will feature leading experts discussing breakthrough therapies, offering valuable insights for investors and stakeholders in the biotech sector.
For an in-depth examination of INM stock, go to TipRanks’ Stock Analysis page.
